ATE207914T1 - Alpha-liponsäure in kristalliner form - Google Patents

Alpha-liponsäure in kristalliner form

Info

Publication number
ATE207914T1
ATE207914T1 AT99104155T AT99104155T ATE207914T1 AT E207914 T1 ATE207914 T1 AT E207914T1 AT 99104155 T AT99104155 T AT 99104155T AT 99104155 T AT99104155 T AT 99104155T AT E207914 T1 ATE207914 T1 AT E207914T1
Authority
AT
Austria
Prior art keywords
alpha
crystalline form
liponic acid
enantiomer
acid
Prior art date
Application number
AT99104155T
Other languages
German (de)
English (en)
Inventor
Thomas Dr Beisswenger
Eberhard Oestreich
Karl-Friedrich Dr Landgraf
Gunter Dr Laban
Matthias Dr Rischer
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of ATE207914T1 publication Critical patent/ATE207914T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Seasonings (AREA)
AT99104155T 1998-03-11 1999-03-02 Alpha-liponsäure in kristalliner form ATE207914T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19810336A DE19810336A1 (de) 1998-03-11 1998-03-11 Alpha-Liponsäure mit neuartiger Modifikation
US09/074,645 US5994393A (en) 1998-03-11 1998-05-08 Alpha-lipoic acid with novel modification

Publications (1)

Publication Number Publication Date
ATE207914T1 true ATE207914T1 (de) 2001-11-15

Family

ID=26044524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99104155T ATE207914T1 (de) 1998-03-11 1999-03-02 Alpha-liponsäure in kristalliner form

Country Status (10)

Country Link
US (1) US5994393A (enExample)
EP (1) EP0949258B1 (enExample)
AT (1) ATE207914T1 (enExample)
CA (1) CA2265276C (enExample)
CY (1) CY1106435T1 (enExample)
DE (2) DE19810336A1 (enExample)
DK (1) DK0949258T3 (enExample)
ES (1) ES2164474T3 (enExample)
IN (1) IN186598B (enExample)
PT (1) PT949258E (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834608A1 (de) * 1998-07-31 2000-02-03 Basf Ag Kristallmodifikation der Liponsäure
DK1294353T3 (da) * 2000-06-06 2006-07-10 Basf Ag Anvendelse af en (R) -enantiomer af liponsyre i kosmetiske og dermatologiske sammensætninger
DE10151764A1 (de) * 2001-10-19 2003-05-08 Basf Ag Kombination von Liponsäure und Glutamin in Lebens- und Arzneimitteln
CN101107012A (zh) * 2004-11-24 2008-01-16 希尔氏宠物营养品公司 改进动物异生素物质肝清除率的方法
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
CA2784197C (en) 2004-12-30 2015-09-01 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
CA2745383A1 (en) * 2008-12-01 2010-06-10 In Vasc Therapeutics, Inc. Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system related disorders
CN108484570B (zh) * 2018-05-15 2021-05-04 苏州富士莱医药股份有限公司 一种制备硫辛酸颗粒的方法及设备

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2115589T3 (es) * 1989-11-09 1998-07-01 Asta Medica Ag Medicamento que contiene acido r-alfa-liponico o acido s-alfa-liponico como sustancia activa.
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
DE4235912C2 (de) * 1992-10-23 2002-12-05 Viatris Gmbh Verfahren zur Herstellung kristalliner Thioctsäure und deren Verwendung
DE4433764A1 (de) * 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit

Also Published As

Publication number Publication date
ES2164474T3 (es) 2002-02-16
DE19810336A1 (de) 1999-09-23
CA2265276A1 (en) 1999-09-11
IN186598B (enExample) 2001-10-06
EP0949258A1 (de) 1999-10-13
DK0949258T3 (da) 2002-01-28
PT949258E (pt) 2002-04-29
CY1106435T1 (el) 2011-04-06
CA2265276C (en) 2009-09-08
US5994393A (en) 1999-11-30
EP0949258B1 (de) 2001-10-31
DE59900364D1 (de) 2001-12-06

Similar Documents

Publication Publication Date Title
EP1408084A3 (en) Epoxy resin compositions for the manufacture of void-free laminates
CA2349227A1 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
EP0702953A3 (de) Darreichungsformen enthaltend Thioctsäure, oder feste Salze von Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
AU5267286A (en) Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido) azabicycloalkanes
AU603525B2 (en) Tetrazole intermediates to antihypertensive compounds
WO2004011453A3 (en) Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles
CA2183315A1 (en) Novel Mercaptoacetylamido 1,3,4,5-Tetrahydro-Benzo[c]azepin-3-One Disulfide Derivatives Useful as Inhibitors of Enkephalinase and Ace
DE59900364D1 (de) Alpha-Liponsäure in kristalliner Form
AU5581190A (en) Diarylstrylquinoline diacids
IL140826A0 (en) Crystal modification of lipoic acid
EA200100194A1 (ru) КРИСТАЛЛИЧЕСКИЕ ФОРМЫ ETO2C-CH2-(R)Cgl-Aze-Pab-OH
CA2333008A1 (en) New heterocyclically substituted amides, their production and their use
GB8320203D0 (en) Anti-viral compositions
ZA200207675B (en) Novel crystal form of pyrrolidylthiocarbapenem derivative.
IE42628L (en) 1,3,4-oxadiazoline derivatives
AU662409B2 (en) A method for preparing low free formaldehyde methylolhydantoins and compositions thereof
ATE35413T1 (de) Cephalosporinverbindungen und ihre herstellung.
IE45109L (en) N-2-imidazolidinylidene-benzeneamine
EP1692952A3 (en) Flavouring a foodstuff with compounds containing a sulphur atom linked to two specific atoms or groups
BR9808637A (pt) Compostos e método de preparação de ácidos 4-fenil-4 cianociclohexanóico
AU571077B2 (en) Fungicidal naphthylalkylamines
EP0150064A3 (en) 3-amino-4-fluorophenylethers and their production
AU562643B2 (en) N-arylpiperazine derivatives
IE840151L (en) £(3, 4-methylenedioxy-ó-hydroxybenzyl| pyrrolidine¹antihypertensives
JP2001023686A5 (enExample)

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner